RetinaLyze is a technology company specializing in the development of innovative solutions for the early detection and management of retinal diseases. The company focuses on leveraging advanced artificial intelligence and machine learning algorithms to analyze retinal images, enabling healthcare professionals to diagnose conditions such as diabetic retinopathy and age-related macular degeneration more efficiently. RetinaLyze aims to improve patient outcomes through timely intervention and enhanced screening processes in ophthalmology.